Bioequivalence of mirabegron 50 mg extended release Tablet [Design Issues]

posted by qualityassurance – 2022-08-04 17:47 (820 d 16:09 ago) – Posting: # 23202
Views: 3,881

Dear Ibrahim,

❝ Knowing that I couldn't find an accurate data for intrasubject variability of Mirabegnon.


I know it is very late response but here you can find the literature mentioning the high variability of mirabegron (approximately 33% to 45% for Cmax and 19% to 31% for AUC) AUS PAR.

Hope it may help other forum members.

Regards.

Complete thread:

UA Flag
Activity
 Admin contact
23,279 posts in 4,889 threads, 1,657 registered users;
68 visitors (0 registered, 68 guests [including 9 identified bots]).
Forum time: 08:56 CET (Europe/Vienna)

Pharmacokinetics: one of the magic arts of divination
whereby needles are stuck into dummies in an attempt
to predict profits.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5